Cognizant and Agorai team set to pitch Sensyne’s digital healthcare solutions to US
Oxford-based clinical artificial intelligence (AI) specialists, Sensyne Health, has appointed IT services provider Cognizant and data infrastructure specialist Agorai to promote its digital healthcare services in the US. This marketing support will focus on three of the company’s latest innovations – GDm-Health (therapeutic software designed to help manage gestational diabetes); EDGE (a program for the in-home monitoring of chronic obstructive pulmonary disorder); and Support-HF (an in-home system for tracking vital signs in the wake of a coronary episode).
Outlining the rationale behind the appointments, Lord Paul Drayson, Sensyne’s CEO, said together Cognizant and Agorai would ensure the full potential of the company’s innovative product range could be realized in the US market. Outlining the likely timeline, he said Cognizant will provide US healthcare providers with the requisite digital health applications once the appropriate regulatory approvals had been secured, with GDm-Health set to be the first of the company’s products to be available in the US.
